{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T16:09:04Z","timestamp":1789056544625,"version":"build-2803163510"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.rmed.2026.109096","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T15:22:20Z","timestamp":1786029740000},"page":"109096","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Correlation between pulmonary outcomes and nutritional status following treatment with elexacaftor\/tezacaftor\/ivacaftor in people with Cystic fibrosis"],"prefix":"10.1016","volume":"262","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7119-5675","authenticated-orcid":false,"given":"Malena","family":"Cohen-Cymberknoh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuval","family":"Aqua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giselle","family":"Diab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Prais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hagit","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Yaacoby-Bianu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galit","family":"Livnat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8073-3973","authenticated-orcid":false,"given":"Moshe","family":"Heching","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6259-405X","authenticated-orcid":false,"given":"Inbal","family":"Golan-Tripto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liora","family":"Boehm Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0055-5415","authenticated-orcid":false,"given":"Ronen","family":"Bar-Yoseph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2565-4185","authenticated-orcid":false,"given":"Joel","family":"Reiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Gur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.rmed.2026.109096_bib1","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1164\/rccm.202108-1986OC","article-title":"Clinical effectiveness of Elexacaftor\/Tezacaftor\/Ivacaftor in people with cystic fibrosis A clinical trial","volume":"205","author":"Nichols","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2026.109096_bib2","first-page":"1","article-title":"Impact of elexacaftor\/tezacaftor\/ivacaftor on lung function, nutritional status, pulmonary exacerbation frequency and sweat chloride in people with cystic fibrosis: real-world evidence from the German CF registry","volume":"32","author":"Sutharsan","year":"2023","journal-title":"Lancet Reg Health - Eur."},{"key":"10.1016\/j.rmed.2026.109096_bib3","unstructured":"FDA Approves New Breakthrough Therapy for Cystic Fibrosis | FDA [Internet]. [cited 2024 October 15]. Available from: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-new-breakthrough-therapy-cystic-fibrosis."},{"key":"10.1016\/j.rmed.2026.109096_bib4","series-title":"Combination of Cystic Fibrosis Medicines to Treat Patients with Rare Mutations","year":"2025"},{"issue":"11","key":"10.1016\/j.rmed.2026.109096_bib5","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/S2213-2600(24)00208-X","article-title":"The expanded French compassionate programme for elexacaftor-tezacaftor-ivacaftor use in people with cystic fibrosis without a F508del CFTR variant: a real-world study","volume":"12","author":"Burgel","year":"2024","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.rmed.2026.109096_bib6","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02437-2022","article-title":"The French compassionate program of elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis with advanced lung disease and no F508del CFTR variant","author":"Burgel","year":"2023","journal-title":"Eur. Respir. J."},{"issue":"17","key":"10.1016\/j.rmed.2026.109096_bib7","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1056\/NEJMoa1807120","article-title":"VX-445-tezacaftor-ivacaftor in patients with cystic fibrosis and one or two Phe508del alleles","volume":"379","author":"Keating","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.rmed.2026.109096_bib8","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.jpeds.2016.09.064","article-title":"Diagnosis of cystic fibrosis: Consensus guidelines from the cystic fibrosis foundation","volume":"181","author":"Farrell","year":"2017","journal-title":"J. Pediatr."},{"issue":"1","key":"10.1016\/j.rmed.2026.109096_bib9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1569-1993(02)00141-8","article-title":"Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients","volume":"2","author":"Lee","year":"2003","journal-title":"J. Cyst. Fibros."},{"issue":"7","key":"10.1016\/j.rmed.2026.109096_bib10","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1002\/ppul.25371","article-title":"How abnormal is the normal? Clinical characteristics of CF patients with normal FEV1","volume":"56","author":"Cohen-Cymberknoh","year":"2021","journal-title":"Pediatr. Pulmonol."},{"issue":"2","key":"10.1016\/j.rmed.2026.109096_bib11","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jcf.2017.11.020","article-title":"Attention deficit hyperactivity disorder symptoms in patients with cystic fibrosis","volume":"17","author":"Cohen-Cymberknoh","year":"2018","journal-title":"J Cyst Fibros Off J Eur Cyst Fibros Soc."},{"key":"10.1016\/j.rmed.2026.109096_bib12","first-page":"11","article-title":"Optimizing CFTR modulator therapy management for cystic fibrosis through the ReX platform","author":"Yaacoby-Bianu","year":"2023","journal-title":"Front. Pediatr."},{"issue":"3","key":"10.1016\/j.rmed.2026.109096_bib13","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1183\/20734735.012717","article-title":"The Global Lung Function Initiative (GLI) network: bringing the world's respiratory reference values together","volume":"13","author":"Cooper","year":"2017","journal-title":"Breathe"},{"issue":"1","key":"10.1016\/j.rmed.2026.109096_bib14","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12931-023-02451-0","article-title":"Heterogeneity of weight gain after initiation of Elexacaftor\/Tezacaftor\/Ivacaftor in people with cystic fibrosis","volume":"24","author":"Gramegna","year":"2023","journal-title":"Respir. Res."},{"issue":"6","key":"10.1016\/j.rmed.2026.109096_bib15","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1002\/ppul.26982","article-title":"Predicting weight gain in patients with cystic fibrosis on triple combination modulator","volume":"59","author":"Stewart","year":"2024","journal-title":"Pediatr. Pulmonol."},{"issue":"3","key":"10.1016\/j.rmed.2026.109096_bib16","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/MEG.0b013e3282f36d04","article-title":"The changing face of the exocrine pancreas in cystic fibrosis: the correlation between pancreatic status, pancreatitis and cystic fibrosis genotype","volume":"20","author":"Augarten","year":"2008","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"issue":"6","key":"10.1016\/j.rmed.2026.109096_bib17","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/0895-4356(88)90063-7","article-title":"A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto","volume":"41","author":"Corey","year":"1988","journal-title":"J. Clin. Epidemiol."},{"issue":"18","key":"10.1016\/j.rmed.2026.109096_bib18","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1056\/NEJMra2216474","article-title":"Cystic Fibrosis","volume":"389","author":"Grasemann","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.rmed.2026.109096_bib19","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1164\/rccm.202108-1986OC","article-title":"Clinical effectiveness of Elexacaftor\/Tezacaftor\/Ivacaftor in people with cystic fibrosis: a clinical trial","volume":"205","author":"Nichols","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.rmed.2026.109096_bib20","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jcf.2024.12.006","article-title":"Sweat chloride reflects CFTR function and correlates with clinical outcomes following CFTR modulator treatment","volume":"24","author":"Zemanick","year":"2025","journal-title":"J. Cyst. Fibros."},{"issue":"4","key":"10.1016\/j.rmed.2026.109096_bib21","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.jcf.2025.05.005","article-title":"Long-term outcomes in people with CF lacking FEV1 response to elexacaftor\/tezacaftor\/ivacaftor therapy","volume":"24","author":"Hadhud","year":"2025","journal-title":"J. Cyst. Fibros."},{"issue":"4","key":"10.1016\/j.rmed.2026.109096_bib22","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1378\/chest.13-1162","article-title":"Differences in disease expression between primary ciliary dyskinesia and cystic fibrosis with and without pancreatic insufficiency","volume":"145","author":"Cohen-Cymberknoh","year":"2014","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.rmed.2026.109096_bib23","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1164\/rccm.202411-2231OC","article-title":"Long-term safety and efficacy of Elexacaftor\/Tezacaftor\/Ivacaftor in adults and adolescents with cystic fibrosis and at least one F508del allele: a phase 3 open-label extension study","volume":"211","author":"Daines","year":"2025","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"10","key":"10.1016\/j.rmed.2026.109096_bib24","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1164\/rccm.202502-0512OC","article-title":"Long-term safety and efficacy of Elexacaftor\/Tezacaftor\/Ivacaftor in children \u22656 years with cystic fibrosis and at least one F508del allele: a 192-Week, phase 3, open-label extension study","volume":"211","author":"Wainwright","year":"2025","journal-title":"Am. J. Respir. Crit. Care Med."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611126004646?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611126004646?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:40:57Z","timestamp":1789054857000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611126004646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":24,"alternative-id":["S0954611126004646"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2026.109096","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correlation between pulmonary outcomes and nutritional status following treatment with elexacaftor\/tezacaftor\/ivacaftor in people with Cystic fibrosis","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2026.109096","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109096"}}